Recovery From Paranoia: a Qualitative Exploration
3 other identifiers
observational
15
1 country
1
Brief Summary
Paranoia, the experience of undue or excessive mistrust, exists on a continuum which includes suspicious thoughts, ideas of reference, and persecutory delusions. Persecutory delusions refers to strong unfounded fears that others intend harm. These fears are very common. They affect around 70% of patients with schizophrenia. They can be distressing and make day-to-day tasks difficult. However, current treatments are limited and a significant proportion of people do not benefit sufficiently. Therefore, improvements in treatment are needed. A better understanding of the experience of recovery from paranoia will help inform theoretical understanding and treatment development. Currently we do not fully understand what causes paranoia to occur, persist, or end. As such, it is critical to understand the experiences of those who have recovered, in particular what elements encourage recovery. Therefore, the aim of this study is to gain a first-person perspective on how people recover from paranoia and what psychological processes are important for recovery from paranoia. Using a qualitative approach appropriate for exploratory research, semi-structured interviews will be conducted with 12-15 patients who have recovered from paranoia. Interviews will be analysed using interpretative phenomenological analysis, a qualitative research approach which aims to provide insight on how an individual, in a particular situation, makes sense of their experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedStudy Start
First participant enrolled
June 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2022
CompletedMay 19, 2022
March 1, 2021
2 months
March 25, 2021
May 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Qualitative interview accounts
Semi-structured interpretative phenomenological analysis (IPA) interviews will be used.
March 2021-March 2022
Interventions
Participants will be interviewed about their experiences of recovery from paranoia.
Eligibility Criteria
A sample of approximately 15 patients who have recovered from paranoia will be recruited. Participants will be recruited according to the inclusion and exclusion criteria adumbrated below.
You may qualify if:
- Participant has recovered from the paranoia. This is defined as: A.) conviction in persecution beliefs is rated as less than 10% and B.) not experiencing significant distress related to paranoia and C.) currently scoring outside the clinical range of the revised Green et al., Paranoid Thoughts Scale (R-GPTS; Freeman, 2019);
- Participants should have had experiences of paranoia in the context of non-affective psychosis. This will be determined by participant's agreement that they previously had the sort of thoughts listed in the revised Green et al. Paranoid Thoughts Scale (R-GPTS; Freeman, 2019);
- Participant is currently a patient of Oxford Health NHS Foundation Trust;
- Participant is willing and able to give informed consent for participation in the study;
- Aged 16 years or above;
- Participant has sufficient English language skills to participate in the interview.
You may not qualify if:
- Currently experiencing acute psychiatric symptoms which preclude ability to participate in a sustained interview;
- Diagnosis of a moderate to severe intellectual disability;
- High levels of associated risk to self or to others e.g. actively suicidal;
- Primary diagnosis of alcohol or drug misuse; personality disorder; significant forensic history;
- At the time of recruitment COVID-19 restrictions do not permit face-to-face interviews and the participant is not willing or able to conduct the interview remotely via video call.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oxford Health NHS Foundation Trust
Oxford, Oxfordshire, OX3 7JX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dr Felicity Waite, DClinPsy, BSc (Hons)
University of Oxford
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2021
First Posted
April 1, 2021
Study Start
June 9, 2021
Primary Completion
July 27, 2021
Study Completion
February 16, 2022
Last Updated
May 19, 2022
Record last verified: 2021-03